Log In
BCIQ
Print this Print this
 

WBI-1001

  Manage Alerts
Collapse Summary General Information
Company Welichem Biotech Inc.
DescriptionTopical non-steroidal and non-immunosuppressive anti inflammatory compound
Molecular Target
Mechanism of ActionNSAID
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$34.2M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/30/2012

Undisclosed

$34.2M

Undisclosed

Get a free BioCentury trial today